03/01/2013 [ACCESSWIRE]

NEW YORK, March 01, 2013 - vb-news.net, one of the leaders in providing investment alerts on U.S. stocks are announcing Investment Highlights on Microsoft Corporation, Pfizer Inc, Amgen Inc.

It is a matter for debate whether citizens in the United Kingdom are thrilled by this - but Microsoft Corporation(NASDAQ:MSFT) is releasing its Surface Pro tablets in the island country in late March.

Is MSFT ready To Move Back To New Highs After The Recent Retreat? Find Out Here http://vbtrendreport.com/aw/?code=MSFT

In fact the company has lined up a whole host of countries where it will be available. Going beyond the United States and Canada, the tablet PC from Microsoft will soon be available in Australia, China, France, Germany, Hong Kong, and New Zealand, according to an announcement from the company.

The Surface Pro has received a better response compared to the surface RT, which is meant for retail customers. It was sold out in its opening weekend.

The Surface RT will also go into other markets such as Japan, Mexico, New Zealand, Russia, Singapore and Taiwan.

Pfizer Inc.(NYSE:PFE) - The U.S. Food and Drug Administration has approved the use of a Bayer cancer pill to treat tumours of the intestinal tract. 

How Should Investors Trade PFE At New highs? Get Free Research Report Here http://vbtrendreport.com/aw/?code=PFE

Stivarga has been approved to treat gastrointestinal stromal tumours that cannot be surgically removed and no longer respond to other FDA-approved drugs.

Earlier Bayer had received approval to use the drug to treat colorectal cancer, which it did by blocking several enzymes that promoted cancer growth.

The FDA approved the drug for the new use based on a study of nearly 200 patients who were randomly assigned to take Stivarga or a placebo pill.  

The U.S. Supreme Court has allowed investors to join a class action suit brought again drug firm Amgen, Inc.(NASDAQ:AMGN) for not attaching sufficient importance to the safety concerns of two anaemia drugs. 

How Can Investors Trade AMGN As The Stock Hitting New highs? Let’s Grab Free Report Here http://vbtrendreport.com/aw/?code=AMGN

Connecticut Retirement Plans and Trust Funds, which brought the suit on behalf of Amgen stock buyers, said the company had minimized the risks of taking anaemia drugs Aranesp and Epogen.

The court ruling made it easier for shareholders to band together in a class suit without having to first show that misinformation had inflated the company's stock price materially or fraudulently.

About vb-news.net

vb-news.net’s team is engaged in providing stock newsletters on various hot penny stocks on a regular basis. Our instant stock news on Major Gainers, small cap penny stocks and various other stocks, guides investors in making the wise stock market investments decision. In order to get update to the markets, we would advise you sign up to our free newsletters. You can become leader in stock market by keeping track of the daily activity.

Disclaimer

The assembled information disseminated by vb-news.net is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. vb-news.net does expect that investors will buy and sell securities based on information assembled and presented in vb-news.net. PLEASE always do your own due diligence, and consult your financial advisor.

Contacts:

vb-news.net
1419 Westwood Blvd Los Angeles, CA
90024-4911
staff@vb-news.net
www.vb-news.net